The prevalence of heart failure and asymptomatic left ventricular systolic dysfunction in a typical regional

Simon D R Thackray1, Klaus K A Witte, Nikolay P Nikitin

  • 1Castle Hill Hospital, University of Hull, Cottingham, Hull, UK. simonthackery@hotmail.com

Insights

Heart failure is common in patients with pacemakers, affecting 31% of those studied. Many cases of heart failure and left ventricular systolic dysfunction go undiagnosed in this high-risk population.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Research

Background:

  • Chronic pacing is a common intervention for various cardiac conditions.
  • Left ventricular systolic dysfunction (LVSD) can be a consequence of long-term pacing.
  • Early detection of heart failure (HF) in paced patients is crucial for management.

Purpose of the Study:

  • To determine the prevalence of heart failure and asymptomatic LVSD in patients with long-term pacemakers.
  • To identify risk factors associated with HF in this population.

Main Methods:

  • Retrospective analysis of 307 patients attending pacemaker follow-up.
  • Inclusion of medical history, physical examination, 6-minute walk test, and echocardiography.
  • Assessment of left ventricular ejection fraction (LVEF) and heart failure symptoms (NYHA classification).

Main Results:

  • 31% of patients had LVEF <40%, indicating LVSD.
  • 83% of those with LVSD presented with symptomatic heart failure (NYHA II-IV).
  • Higher HF prevalence observed in single-chamber vs. dual-chamber pacing and in chronic atrial fibrillation vs. sinus rhythm.

Conclusions:

  • Heart failure due to LVSD is a significant issue in the chronically paced population.
  • A substantial number of HF cases in paced patients are undiagnosed or undertreated.
  • Echocardiographic screening is recommended for early diagnosis and improved management of HF in this high-risk group.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...